Aandeel REMI REMEDENT, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Remedent, Inc. Other OTC

Aandelen

REMI

US75954T1043

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
Remedent : Attorney Letter - Lockett + Horwitz - Remedent, Inc. 2022-06-30 - re Annual Report
Remedent : Annual Report for Year Ended March 31, 2022
REMEDENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies
Remedent announces its agreement with Aurum Ceramic Dental Laboratories Co., concerning an Exclusive Master License Agreement in reference to its GlamSmile Veneers and Technology
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
REMEDENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers REMI
  4. Koers REMI
  5. Nieuws Remedent, Inc.
  6. Andere talen